Correlation Between PCI Biotech and Navamedic ASA

Can any of the company-specific risk be diversified away by investing in both PCI Biotech and Navamedic ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PCI Biotech and Navamedic ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PCI Biotech Holding and Navamedic ASA, you can compare the effects of market volatilities on PCI Biotech and Navamedic ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PCI Biotech with a short position of Navamedic ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of PCI Biotech and Navamedic ASA.

Diversification Opportunities for PCI Biotech and Navamedic ASA

0.06

Correlation Coefficient

PCI Biotech  Navamedic ASA

Significant diversification

The 3 months correlation between PCI and Navamedic is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding PCI Biotech Holding and Navamedic ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navamedic ASA and PCI Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PCI Biotech Holding are associated (or correlated) with Navamedic ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navamedic ASA has no effect on the direction of PCI Biotech i.e., PCI Biotech and Navamedic ASA go up and down completely randomly.

Pair Corralation between PCI Biotech and Navamedic ASA

Assuming the 90 days trading horizon PCI Biotech Holding is expected to generate 2.26 times more return on investment than Navamedic ASA. However, PCI Biotech is 2.26 times more volatile than Navamedic ASA. It trades about 0.05 of its potential returns per unit of risk. Navamedic ASA is currently generating about -0.1 per unit of risk. If you would invest  150.00  in PCI Biotech Holding on November 29, 2024 and sell it today you would earn a total of  10.00  from holding PCI Biotech Holding or generate 6.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PCI Biotech Holding  vs.  Navamedic ASA

PCI Biotech Holding

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in PCI Biotech Holding are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, PCI Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Navamedic ASA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Navamedic ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with PCI Biotech and Navamedic ASA

The main advantage of trading using opposite PCI Biotech and Navamedic ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PCI Biotech position performs unexpectedly, Navamedic ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navamedic ASA will offset losses from the drop in Navamedic ASA's long position.

The idea behind PCI Biotech Holding and Navamedic ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.